Mekaroonkamol Parit, Dacha Sunil, Patel Vaishali, Li Baiwen, Luo Hui, Shen Shanshan, Chen Huimin, Cai Qiang
Division of Digestive Diseases, Emory University School of Medicine, 615 Michael Street, Suite 201, Atlanta, GA 30322, USA.
Division of Digestive Diseases, Emory University School of Medicine, 615 Michael Street, Suite 201, Atlanta, GA 30322, USA.
Gastrointest Endosc Clin N Am. 2019 Jan;29(1):151-160. doi: 10.1016/j.giec.2018.08.009. Epub 2018 Sep 22.
Per oral endoscopic pyloromyotomy (POP) has emerged as an endoscopic intervention for refractory gastroparesis. Early experience in the United States showed exciting clinical response rate, reduced gastroparesis symptoms, improved quality of life, and decreased gastric-emptying time during midterm follow-up up to 18 months. One recent study also showed that the number of patient emergency room visits and hospitalizations decreased significantly after POP. The procedure is technically feasible and safe. As more data become available, it is important to identify patients who would benefit most from this novel procedure.
经口内镜幽门肌切开术(POP)已成为一种用于难治性胃轻瘫的内镜干预方法。美国的早期经验显示出令人振奋的临床缓解率,胃轻瘫症状减轻,生活质量改善,并且在长达18个月的中期随访期间胃排空时间缩短。最近的一项研究还表明,POP术后患者急诊就诊和住院的次数显著减少。该手术在技术上可行且安全。随着更多数据的获取,识别出最能从这种新手术中获益的患者很重要。